(Q39731191)

14 September 2017

Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist (English)

1 reference

14 September 2017

Sean P Brown

1

1 reference

14 September 2017

Paul J Dransfield

2

1 reference

14 September 2017

Marc Vimolratana

3

1 reference

14 September 2017

XianYun Jiao

4

1 reference

14 September 2017

Liusheng Zhu

5

1 reference

14 September 2017

Vatee Pattaropong

6

1 reference

14 September 2017

Ying Sun

7

1 reference

14 September 2017

Jinqian Liu

8

1 reference

14 September 2017

Jian Luo

9

1 reference

14 September 2017

Jane Zhang

10

1 reference

14 September 2017

Simon Wong

11

1 reference

14 September 2017

Run Zhuang

12

1 reference

14 September 2017

Qi Guo

13

1 reference

14 September 2017

Frank Li

14

1 reference

14 September 2017

Julio C Medina

15

1 reference

14 September 2017

Gayathri Swaminath

16

1 reference

14 September 2017

Daniel C-H Lin

17

1 reference

14 September 2017

Jonathan B Houze

18

1 reference

14 September 2017

language of work or name

1 reference

15 August 2012

1 reference

ACS Medicinal Chemistry Letters

14 September 2017

1 reference

14 September 2017

3

1 reference

14 September 2017

9

1 reference

14 September 2017

726-730

1 reference

Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

Catalysts for Suzuki-Miyaura coupling processes: scope and studies of the effect of ligand structure

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

AMG 837: a potent, orally bioavailable GPR40 agonist.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025659

Rhodium-catalyzed asymmetric 1,4-addition and its related asymmetric reactions

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24900539

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/ML300133F

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

24900539

1 reference